Google parent company Alphabet’s venture fund CapitalG led the funding round, which also included St. Louis-based Ascension Ventures. The new investment brings Strive Health’s funding to $223.5 million, according to a news release.
Strive Health’s data and artificial intelligence models aim to slow kidney disease progression, prevent unnecessary and costly hospitalizations, and expand access to renal replacement therapies including home dialysis and transplants. Strive Health has contracts with healthcare organizations Humana, Blue Shield of North Carolina and SSM Health, among others.
Under the new partnership with CapitalG, Strive Health will get access to Google and Alphabet’s expertise and advice for product innovation.
More articles on digital transformation:
8 recent health IT, innovation partnerships
Abbott launches pandemic defense coalition to study virus variants, future viral outbreaks
Walgreens rolls out voicebot to help customers schedule vaccine appointments
